Pre-market: CLV.AX Clover Corporation (ASX) earnings 21 Mar 2026: focus on guidance

CLV.AX stock trades at A$0.77 pre-market on 21 Mar 2026 as investors position ahead of Clover Corporation Limited’s earnings due later this month. The market cap is A$128.59m and shares outstanding are 166,999,341. Key near-term drivers include March earnings guidance, recent margin metrics, and low intraday volume at 15,658 shares. We examine valuation, forecasts and risks ahead of the report.

Earnings calendar and near-term catalyst for CLV.AX stock

Clover’s next earnings announcement is scheduled for 24 Mar 2026, a primary catalyst for CLV.AX stock. Investors will watch revenue trends and guidance for Nu‑Mega and Ocean Gold product lines. Expect management commentary on margins and export demand, which can move the stock in the pre‑market and early trade sessions.

Financial snapshot and valuation for CLV.AX stock

Clover trades at A$0.77 with EPS A$0.04 and a reported PE of 19.25. Price to sales is 1.50 and price to book is 1.78, signalling modest valuation versus peers. The company shows a strong current ratio of 4.66, low debt to equity 0.03, and dividend yield near 2.27%, supporting a defensive profile in the Consumer Defensive sector.

Meyka AI grade and forecast for CLV.AX stock

Meyka AI rates CLV.AX with a score out of 100: 67.71 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly price of A$1.02, implying +32.27% from the current A$0.77. Forecasts are model-based projections and not guarantees.

Technical and trading setup for CLV.AX stock

Momentum indicators are neutral: RSI 51.24, MACD flat, and ADX 15.60 indicating no strong trend. Bollinger Band middle sits at A$0.76 with upper band A$0.79. Trading volume is subdued at 15,658 versus average 128,608, suggesting limited liquidity and potential for wider spreads on earnings news.

Sector context and risks for CLV.AX stock

Clover sits in the Consumer Defensive Packaged Foods industry, where six‑month sector performance is weaker at -7.94%. Packaged Foods peers can offer higher scale and liquidity. Key risks include commodity price swings for marine oils, receivables cycle (days sales outstanding 106.59) and inventory days 147.27, which can pressure cash conversion during demand shifts.

Analyst view, price targets and scenarios for CLV.AX stock

Recent company ratings show an A‑ recommendation (Buy) from third‑party analysis dated 19 Mar 2026, reinforcing near‑term optimism. Short term model targets are A$0.80 (monthly) and A$0.81 (quarterly). Upside scenario to A$1.02 assumes margin recovery and stronger export sales. Downside to A$0.60 could follow weaker guidance or a slowdown in infant nutrition demand.

Final Thoughts

Key takeaways for CLV.AX stock: Clover trades at A$0.77 pre-market on 21 Mar 2026, with compact market capitalisation A$128.59m, PE 19.25, and defensively strong liquidity ratios. The immediate trigger is the upcoming earnings announcement on 24 Mar 2026, where guidance and margin commentary will steer short-term price action. Meyka AI’s forecast model projects a yearly price of A$1.02, implying +32.27% upside versus today’s price. Our internal grade is B (HOLD), reflecting solid fundamentals but limited liquidity and sector headwinds. Traders should watch volume and management guidance; longer-term investors may consider phased exposure if earnings confirm margin recovery. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.